Insider track record Other Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Reents Scott T. Director active across 1 company, notably AbbVie Inc.. Aggregated, 16 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €3.5m. Activity tracked since 16 February 2023. The latest transaction was disclosed on 14 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 16 total
▼ EVP, CHIEF FINANCIAL OFFICER · Executives · 14 Mar 2025 · AbbVie Inc. 17,644 shares @ US$212.34 41.8% of flow Common Stock, $0.01 par value SEC:0001415889-25-008437:0
● EVP, CHIEF FINANCIAL OFFICER · Executives · 28 Feb 2025 · AbbVie Inc. 10,973 shares @ US$205.02 26.2% of flow Common Stock, $0.01 par value SEC:0001415889-25-006584:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 13 Feb 2025 · AbbVie Inc. 5,845 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004458:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 13 Feb 2025 · AbbVie Inc. 2,398 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004458:1
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 13 Feb 2025 · AbbVie Inc. 8,912 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004458:2
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 13 Feb 2025 · AbbVie Inc. 7,608 shares 0Common Stock, $0.01 par value SEC:0001415889-25-004458:3
◇ EVP, CHIEF FINANCIAL OFFICER · Executives · 23 Feb 2024 · AbbVie Inc. 14,140 shares @ US$61.36 9.7% of flow Common Stock, $0.01 par value SEC:0001415889-24-006165:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 15 Feb 2024 · AbbVie Inc. 11,800 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004419:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 15 Feb 2024 · AbbVie Inc. 3,146 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004419:1
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 15 Feb 2024 · AbbVie Inc. 2,398 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004419:2
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 15 Feb 2024 · AbbVie Inc. 8,912 shares 0Common Stock, $0.01 par value SEC:0001415889-24-004419:3
● EVP, CHIEF FINANCIAL OFFICER · Executives · 28 Feb 2023 · AbbVie Inc. 12,683 shares @ US$154.28 22.3% of flow Common Stock, $0.01 par value SEC:0001415889-23-003854:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 16 Feb 2023 · AbbVie Inc. 18,715 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002942:0
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 16 Feb 2023 · AbbVie Inc. 4,366 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002942:1
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 16 Feb 2023 · AbbVie Inc. 3,146 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002942:2
◆ EVP, CHIEF FINANCIAL OFFICER · Executives · 16 Feb 2023 · AbbVie Inc. 2,398 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002942:3